MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Prevalence of GBA parkinsonism in Slovak Parkinson’s disease population

    A. Lacková, V. Han, P. Pavelekova, Z. Gdovinova, M. Skorvanek, K. Kulcsarova, M. Ostrozovicova, T. Lorincova, P. Bauer, CH. Beetz, S. Oppermann, E. Tusay, B. Kovacova, B. Stasko, E. Petro, S. Bohacova (Košice, Slovakia)

    Objective: Our study aimed to determine the prevalence of GBA parkinsonism in the Slovak population with Parkinson's disease (PD). Background: In recent years, there has…
  • 2022 International Congress

    Chronotype and Cognition in Veterans with Parkinson’s Disease

    A. Sarwar (Houston, USA)

    Objective: To determine if chronotype impacts the expression of dementia and/or depression in Veterans with Parkinson's disease (PD). Background: Chronotype reflects the periodicity of biological…
  • 2022 International Congress

    WATCH-PD: Detecting Early-Stage PD using Feature Engineering and Machine Learning in Remote Sensor-Based Assessments

    D. Anderson, M. Merickel, B. Severson, D. Amato, T. Kangarloo, J. Edgerton, R. Dorsey, J. Adams, S. Jezewski, A. Keil, S. Johnson, M. Kantartjis, S. Polyak, J. Severson, J. Cosman (Horsham, USA)

    Objective: Use feature engineering and machine learning to evaluate digital biomarkers of early-stage Parkinson’s disease (PD) in the WATCH-PD study. Background: WATCH-PD – a one-year…
  • 2022 International Congress

    Detecting Parkinson’s Disease from body limb acceleration using machine learning and a frequency-domain analysis

    C. Cermeño-Silveira, JI. Godino-Llorente, A. Muñoz-Gonzalez, J. Perez-Sanchez, M. Gonzalez-Sanchez, F. Grandas-Perez, D. Torricelli (Madrid, Spain)

    Objective: To test whether the acceleration frequency of different body parts during gait can reveal characteristic patterns of Parkinson’s Disease (PD). The technical aim was…
  • 2022 International Congress

    Amygdala-hippocampus damage critically contributes to visual dysfunction in Parkinson disease

    P. Reyero, A. Erramuzpe, A. Murueta-Goyena, A. Jimenez-Marin, M. Acera, S. Teijeira-Portas, B. Tijero, R. Del Pino, T. Fernández-Valle, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, U. Ayala, M. Barrenechea, A. Cabrera-Zubizarreta, J. Cortes, J. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To delineate the structural and functional alterations of the brain associated with visual dysfunction and retinal injury in Parkinson disease (PD) Background: Several electrophysiological,…
  • 2022 International Congress

    Characterization of neuromelanin MRI as a potential Parkinson’s Disease biomarker in a multi-site longitudinal study

    M. Ingalhalikar, H. Pham, L. Bracoud, RM. Hutchison, K. Evans, T. Dam, M. Sampat, J. Schaerer, C. Conklin, J. Suhy, D. Scott (San Mateo, USA)

    Objective: To investigate (1)longitudinal change and (2)cross-sectional vendor differences in neuromelanin MRI in substantia nigra pars compacta(SNpc) in PD patients. Background: Neuromelanin(NM) MRI is a…
  • 2022 International Congress

    Neuroanatomical underpinnings of apathy in Parkinson’s Disease

    C. Le Heron, E. Huey, N. Vanegas-Arroyave, Y. Gazes, S. Lee (New Zealand)

    Objective: To investigated the integrity of white matter tracts within basal ganglia-frontal networks in PD patients with and without apathy, and relate these to specific…
  • 2022 International Congress

    A Narrative Review of Literature on Exercise Therapy and Cognitive Impairment in Individuals with Parkinson’s Disease: The Role of Epigenetics as a Mediator.

    T. Adeniji, S. Olsen, N. Signal, J. Adeleke (Akoda-Ede, Nigeria)

    Objective: This narrative review explored the potential role of exercise as an epigenetic mediator of cognitive function in people with PD and the possible underlying…
  • 2022 International Congress

    Trends in incidence of hospitalizations in Parkinson´s Disease in Spain (2010-2019)

    V. Gómez-Mayordomo, R. Jiménez-García, E. Sanesteban-Beceiro, E. López-Valdés, R. García-Ramos, F. Alonso-Frech (Madrid, Spain)

    Objective: To estimate the incidence of in-hospital admissions of Parkinson´s disease (PD) in Spain during the last decade (2010-2019) and describe the epidemiology of these…
  • 2022 International Congress

    Inflammatory changes in subjects with de novo Parkinson’s disease

    T. Yacoubian, A. Gerstenecker, Y. Fang, A. Amara, N. Stover, L. Ruffrage, C. Collette, R. Kennedy, Y. Zhang, H. Qin, E. Benveniste, J. Mcconathy, D. Standaert (Birmingham, USA)

    Objective: To examine whether inflammation is present in subjects newly diagnosed with Parkinson’s disease (PD). Background: Evidence for the role of inflammation in PD has…
  • « Previous Page
  • 1
  • …
  • 634
  • 635
  • 636
  • 637
  • 638
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley